- Home
- VRCA vs NMTC Comparison
VRCA vs NMTC Comparison
Compare VRCA & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VRCA | NMTC |
|---|---|---|
| Founded | 2013 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 87.5M | 42.6M |
| IPO Year | 2018 | 2010 |
Fundamental Metrics
Financial Performance| Metric | VRCA | NMTC |
|---|---|---|
| Price | $6.05 | $0.77 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $17.00 | $1.98 |
| AVG Volume (30 Days) | 125.6K | ★ 221.2K |
| Earning Date | 06-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 80.43 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $35,577,000.00 | $9,097,692.00 |
| Revenue This Year | $372.93 | N/A |
| Revenue Next Year | N/A | $31.17 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 370.22 | 163.47 |
| 52 Week Low | $0.39 | $0.40 |
| 52 Week High | $9.82 | $1.15 |
Technical Indicators
Market Signals| Indicator | VRCA | NMTC |
|---|---|---|
| Relative Strength Index (RSI) | 51.31 | 49.00 |
| Support Level | $5.22 | $0.69 |
| Resistance Level | $6.44 | $0.89 |
| Average True Range (ATR) | 0.46 | 0.06 |
| MACD | 0.16 | 0.01 |
| Stochastic Oscillator | 70.51 | 46.72 |
Price Performance
Historical ComparisonAbout VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.
About NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.